Luke Lango’s Early Stage Investor Review

Early Stage Investor is an investing service from Luke Lango that claims to find good investments in early trends.

There's a heavy emphasis on AI.

Is this newsletter a scam or a legit opportunity?

We'll explore that in this review.

Additionally, we'll look at any red flags I can find about Early Stage Investor (and there are plenty).

You'll know if it's worth it by the time you're done reading.

Let's get started!

Why You Should Avoid InvestorPlace

Before we get into Luke and Early Stage Invsetor I want to comment on the publisher of this newsletter - InvestorPlace.

I don't like InvestorPlace and there's a lot of reasons why.

Here's why I generally avoid any products from this publisher:

Run By A Legitimate Scam Artist

Louis Navellier is the main face at InvestorPlace and he has products that cost over $10,000 at InvestorPlace.

Louis is a repulsive figure that is constantly bragging about how much money he has.

I could stomach Louis' bragging if he earned his wealth legitimately but it's unlikely he got rich from stocks.

He earned his money from selling stock picks and newsletters.. and ripping off customers.

Just two years ago he was fined $30 million for defrauding his customers:

Louis mislead customers about his stock picking track record to sell them a fraudulent product.

The guy is horrible and I personally wouldn't want my money going to his house or car payments.

Owned By MarketWise

Another red flag about InvestorPlace is that it's owned by MarketWise.

Marketwise owns more than a dozen of the most well known investing publishers and launched last summer in 2021 (it's a publicly traded company).

MarketWise is sort of a spin off of Agora which used to be the top dog in the investing world.

But after getting caught defrauding senior citizens many of the publishers fled.

Eventually they came together to create MarketWise.

The problem with InvestoPlace being in the MarketWise umbrella is you'll be cross promoted newsletters from other publishers at MarketWise.

People like Teeka Tiwari from Palm Beach Research Group will be marketed as some trusted expert to you.

In reality Teeka was tossed from Wall Street and can never work there again.

There's just too many scammers, clowns and low quality stock pickers at MarketWise.

Insane Upsells

Lastly, when you buy from InvestorPlace you're going to get an insane amount of upsells.

You see MarketWise is already making well over $500 million in revenue every year and they're not doing that making one time sales.

They reach that high number upselling their current customers.

Their goal is to milk every dollar they can out of you and they're experts at doing it.

Everyday you'll get bombarded with manipulative and persuasive sales presentations for products that cost thousands of dollars.

It's extremely annoying and it's something customers hate.

The last place you want to be in is a InvestorPlace/MarketWise sales funnel.

Revealing Luke's AI Picks?

Luke is marketing this newsletter with a teaser campaign hinting at 7 AI stocks, he refers to as "SUPRMAN."

This is an acronym and each letter represents the name of a company.

The good news is Luke left enough clues in the presentation to figure out these stocks.

So you don't need to buy this newsletter just figure out these stocks.

The stocks are:

Symbotic 

Symbiotic is a company in the warehouse space that makes products that help with inventory management in the supply chain.

They use AI-powered robots to move goods with high efficiency, speed, and flexibility.

Unity Software

Unity Software is a company that provides a real-time 3D platform for creating games, apps, and other immersive experiences.

This platform has been used to create popular games like Among Us, Fall Guys, and Pokemon Go.

Palantir 

Palantir Tech is a company founded by Peter Theil, and the company went public in 2020.

It's an analytic company that's being sued in many sectors such as defense, intelligence, health care, finance, and energy.

It helps customers integrate, analyze, and visualize large, complex data sets.

Recursion Pharmaceuticals 

Recursion Pharmacueticals is a digital biology and AI company that develops new drugs for various diseases.

It combines machine learning, automation, and other technologies.

Mobileye Gloval

Mobileye Global is a company that develops advanced driver assistance systems and makes products for self-driving cars.

It does this through a combination of cameras, computer chips, and software.

This company was initially bought by Intel for $15 billion, was spun off in October 2022, and is once again a publicly traded company.

Appian 

Appian is a company that provides a cloud-based platform for building enterprise software applications with low-code development tools.

It also allows customers to automate the data sources.

Nice Ltd

The last company being recommended by Luke Lango is Nice Ltd.

This company specializes in contact center software and uses AI for digital and workforce engagement management solutions in many different industries.

Recommended: The Best Place To Get Stock Picks

What Do You Get With Early Stage Investor

This is a pretty typical investing newsletter.

Here's a brief overview of what you get:

Special Reports

The special reports act as a sweetener for you to read this newsletter.

We have already reviewed all the stocks from the SUPRMAN Stocks special reports.

In addition, there's a special report that's titled "5 AI Stocks Set For Rapid Short-Term Gains."

These are stocks that are going to rocket, according to Luke, on June 14th because of a Fed decision.

I'm not sure what these stocks are, but it's June 13th as I'm writing this.

So it'll be too late to buy these stocks by the time you're reading this.

Monthly Newsletter

This is a big part of what you're paying for if you buy Early Stage Investor.

Once a month, you'll get a new newsletter that will cover new stock ideas and the market.

The goal is to find companies involved in "megatrends."

You can expect 1 to 2 new investments every month.

Model Portfolio

This is the other main part that you're paying for.

This is where you'll find all the stocks that Luke is recommending with buy prices.

In addition to the portoflio, you'll also get updates on the stocks and buy/sell alerts if need be.

Luke Lango's Early Stage Investor FAQs

Still have some questions about this newsletter?

Here are the answers to any remaining questions:

1) What's the price of an early-stage investor?

This newsletter will cost $1799 per year.

There's a rule that you should follow when paying for stock research.

Never spend more than 1% to 2% of your portfolio on stock research.

The reason for this is that if you spend more, you'll eat into your returns too much, and it'll be impossible to beat the market.

So for this newsletter to make sense, you need to be investing at least $90,000.

Anything under that, and you're handicapping yourself.

2) Is there a refund policy?

Nope!

There's a 90-day "satisfaction guarantee," but there's no way to get your money back once you pay.

You only get a credit that you can use to buy other InvestorPlace newsletters.

So really, be sure you want this newsletter before you buy.

3) Is Luke Lango legit?

Ehhh.

It's really hard for me to say any of these MarketWise or InvestorPlace people are legit.

First of all, you're working for a guy who was fined $30 million for fraud.

You need loose morals to expose your subscribers to that guy.

And I've been following Lango for years now, and his stock picks never really seem to work out.

His other newsletters have absolute bombs for picks.

For example, Lango said Ilika was his #1 EV stock of the decade and recommended buying it for $3.

In less than a year, the stock was worth $0.50.

There are many instances of this happening with Luke.

4) Are there similar newsletters?

Yes, there are many newsletters just like this one.

Some include:

• The Distortion Report
• Stansberry Investment Advisory
• TradeStops
• Retirement Watch
• Intelligent income investor
• True Wealth
• The Opportunistic Trader
• Jeff Clark, Trader
• Behind the Markets
• The Oxford Income Letter
• Power Gauge Report
• Chaikin Analytics
• Innovation Investor

As you can see, there's no shortage of people wanting to sell you stock picks.

Recommended: The Best Place To Get Stock Picks

Final Thoughts

So that's the end of my review of Early Stage Investor.

I've covered multiple Luke Lango newsletters at this point and have followed a dozen of his stock picks over the last year.

He likes recommending high-risk, high-reward stocks, and that just hasn't been working out for him lately.

Almost all the picks I've seen him make are down pretty significantly.

Will he be able to turn it around?

Maybe, but he's not really showing signs of doing it.

You also shouldn't be giving him thousands of dollars for stock picks right now.

There are better alternatives out there.

Stick with those.